Pharmacogenetic & Pharmacokinetic Biomarker for Efavirenz Based ARV and Rifampicin Based Anti-TB Drug Induced Liver Injury in TB-HIV Infected Patients-Reference-Cited by-同舟云学术

Pharmacogenetic & Pharmacokinetic Biomarker for Efavirenz Based ARV and Rifampicin Based Anti-TB Drug Induced Liver Injury in TB-HIV Infected Patients

Published:2011-12-06 Issue:12 Volume:6 Page:e27810
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Yimer Getnet,Ueda Nobuhisa,Habtewold Abiy,Amogne Wondwossen,Suda Akira,Riedel Klaus-Dieter,Burhenne Jürgen,Aderaye Getachew,Lindquist Lars,Makonnen Eyasu,Aklillu Eleni

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference60 articles.

1. Causes of death in HIV-infected persons who have tuberculosis, Thailand.;KP Cain;Emerg Infect Dis,2009

2. Complications of antiretroviral therapy in patients with tuberculosis: drug interactions, toxicity, and immune reconstitution inflammatory syndrome.;H McIlleron;J Infect Dis,2007

3. Antiretroviral therapy-induced liver alterations.;UA Walker;Curr Opin HIV AIDS,2007

4. Grade 4 events are as important as AIDS events in the era of HAART.;RB Reisler;J Acquir Immune Defic Syndr,2003

5. Antituberculosis drug-induced hepatotoxicity: concise up-to-date review.;A Tostmann;J Gastroenterol Hepatol,2008

Cited by 95 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug-induced hepatotoxicity and association with slow acetylation variants NAT2*5 and NAT2*6 in Cameroonian patients with tuberculosis and HIV co-infection;BMC Infectious Diseases;2024-07-31

2. The Role of Pharmacogenomics Studies for Precision Medicine Among Ethiopian Patients and Their Clinical Implications: A Scoping Review;Pharmacogenomics and Personalized Medicine;2024-07

3. Pharmacogenetic variability of tuberculosis biomarkers in native and mestizo Peruvian populations;Pharmacology Research & Perspectives;2024-04-26

4. Exploring Variability in Rifampicin Plasma Exposure and Development of Anti-Tuberculosis Drug-Induced Liver Injury among Patients with Pulmonary Tuberculosis from the Pharmacogenetic Perspective;Pharmaceutics;2024-03-12

5. SLCO1B1 variants and the risk of antituberculosis drug-induced hepatotoxicity: a systematic review and meta-analysis;Pharmacogenomics;2023-12